Neuralink begins recruiting for first human brain-computer trial

Once in place, the N1 Implant is cosmetically invisible and is intended to record and transmit brain signals wirelessly to an app that decodes movement intention.

Implant’s ultra-fine and flexible threads in a region of the brain that controls movement intention

Elon Musk-owned brain computer interface company Neuralink is now recruiting its first test subjects for human trials to help those with paralysis control devices.

The company said it has received approval from the reviewing independent institutional review board and the first hospital site to begin recruitment for our first-in-human clinical trial.

“The PRIME Study (short for Precise Robotically Implanted Brain-Computer Interface) aims to evaluate the safety of our implant (N1) and surgical robot (R1) and assess the initial functionality of our wireless brain-computer interface for enabling peopl  e with paralysis to control external devices with their thoughts,” the company said in a statement late on Tuesday.

Implant’s ultra-fine and flexible threads in a region of the brain that controls movement intention.

Once in place, the N1 Implant is cosmetically invisible and is intended to record and transmit brain signals wirelessly to an app that decodes movement intention.

“The initial goal of our BCI is to grant people the ability to control a computer cursor or keyboard using their thoughts alone,” said Neuralink.

Those who have quadriplegia due to cervical spinal cord injury or amyotrophic lateral sclerosis (ALS) may qualify for the six-year trial